Lori: FDA decision on medical abortion puts women’s lives, health at risk
By no longer requiring the abortion drug mifepristone to be picked up in person, the U.S. Food and Drug Administration is “merely succumbing to the abortion industry’s pressure to loosen safety standards,” said the U.S. bishops’ pro-life chairman.
Read More
Recent Comments